Yufei Liu, MD, PhD, discussed the importance of careful data interpretation to accurately assess the efficacy of new ...

The annual meeting of the American Society for Radiation Oncology was held from Sept. 29 to Oct. 2 in Washington, D.C., ...

Newly presented data include urine PK data, kidney function assessments and additional safety details. The data demonstrate that there were no adverse findings or clinically relevant changes to any ...

Efforts to make therapeutics from the tiny RNA molecules have been ‘in a little bit of a slump’, but that might soon change.

If you're like the vast majority of individual investors, you've never heard of Scholar Rock, apitegromab, or the ...

RIO DE JANEIRO — A quadruplet induction regimen of isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in the ...

The way forward, then, is to deliver truly personalised medicines and care. For industry, this means developing therapies ...

Istaroxime is a novel first-in-class investigational therapy that is intended to improve systolic contraction and diastolic relaxation of the heart while also increasing blood pressure and maintaining ...

The best threshold for blood transfusions remains controversial in critically ill patients. While a liberal transfusion ...

Hypofractionation of radiation therapy in men with high-risk prostate cancer is not associated with worse survival.

The KAER framework is designed to help primary care providers partner with older adults to engage in shared decision-making ...

Plitidepsin (Aplidin®) demonstrates promise as a candidate therapy in the management of moderate COVID-19 in hospitalized adults requiring oxygen supplementation.